Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Chemed Corporation stock logo
CHE
Chemed
$547.16
+0.1%
$518.67
$365.20
▼
$562.24
$7.12B0.5163,595 shs169,032 shs
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$13.77
-2.8%
$12.85
$6.05
▼
$15.66
$5.39B1.356.87 million shs6.60 million shs
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$15.29
+0.3%
$17.42
$7.07
▼
$20.15
$1.97B1.871.75 million shs1.09 million shs
RadNet, Inc. stock logo
RDNT
RadNet
$71.82
-4.1%
$72.92
$50.82
▼
$85.84
$5.90B1.42767,963 shs811,588 shs
7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Chemed Corporation stock logo
CHE
Chemed
-0.46%+0.52%+6.93%+2.20%+26.59%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
-2.14%-2.68%+20.70%+10.44%+126.72%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
-1.04%-10.08%-8.41%-8.46%+49.22%
RadNet, Inc. stock logo
RDNT
RadNet
-2.56%-3.87%+8.90%-0.82%-2.75%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Chemed Corporation stock logo
CHE
Chemed
$547.16
+0.1%
$518.67
$365.20
▼
$562.24
$7.12B0.5163,595 shs169,032 shs
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$13.77
-2.8%
$12.85
$6.05
▼
$15.66
$5.39B1.356.87 million shs6.60 million shs
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$15.29
+0.3%
$17.42
$7.07
▼
$20.15
$1.97B1.871.75 million shs1.09 million shs
RadNet, Inc. stock logo
RDNT
RadNet
$71.82
-4.1%
$72.92
$50.82
▼
$85.84
$5.90B1.42767,963 shs811,588 shs
7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Chemed Corporation stock logo
CHE
Chemed
-0.46%+0.52%+6.93%+2.20%+26.59%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
-2.14%-2.68%+20.70%+10.44%+126.72%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
-1.04%-10.08%-8.41%-8.46%+49.22%
RadNet, Inc. stock logo
RDNT
RadNet
-2.56%-3.87%+8.90%-0.82%-2.75%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Chemed Corporation stock logo
CHE
Chemed
2.43
Hold$603.0010.21% Upside
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
2.70
Moderate Buy$14.867.90% Upside
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
2.58
Moderate Buy$20.8836.53% Upside
RadNet, Inc. stock logo
RDNT
RadNet
2.78
Moderate Buy$89.6724.85% Upside

Current Analyst Ratings Breakdown

Latest NEO, CHE, RDNT, and LFST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/12/2026
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
Boost Price TargetNeutral$13.00 ➝ $15.00
11/10/2026
RadNet, Inc. stock logo
RDNT
RadNet
Boost Price TargetOverweight$92.00 ➝ $95.00
11/9/2026
RadNet, Inc. stock logo
RDNT
RadNet
DowngradeStrong-Buy ➝ Hold
11/6/2026
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
Boost Price TargetBuy$15.00 ➝ $16.00
11/6/2026
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
Boost Price TargetOverweight$15.00 ➝ $17.00
11/5/2026
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
Boost Price TargetBuy$18.00 ➝ $20.00
11/4/2026
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
Reiterated RatingHold (C)
11/4/2026
RadNet, Inc. stock logo
RDNT
RadNet
Reiterated RatingSell (D-)
10/29/2026
Chemed Corporation stock logo
CHE
Chemed
Boost Price TargetSector Perform$548.00 ➝ $585.00
10/29/2026
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Boost Price TargetBuy$19.00 ➝ $23.00
10/29/2026
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Reiterated RatingBuy$21.00
(Data available from 11/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Chemed Corporation stock logo
CHE
Chemed
$2.53B2.82$24.68 per share22.17$66.19 per share8.27
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$1.42B3.68$0.16 per share84.24$3.93 per share3.50
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$727.33M2.72$0.34 per share45.52$6.19 per share2.47
RadNet, Inc. stock logo
RDNT
RadNet
$2.04B2.77$3.09 per share23.24$18.24 per share3.94
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Chemed Corporation stock logo
CHE
Chemed
$265.24M$20.9023.8621.172.0810.61%35.18%19.43%N/A
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$9.66M$0.1974.5852.96N/A4.29%4.82%3.30%N/A
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
-$108.03M-$0.25N/A509.67N/A-4.10%-0.99%-0.59%N/A
RadNet, Inc. stock logo
RDNT
RadNet
-$18.65M-$0.29138.7471.11N/A-0.94%3.14%1.08%N/A

Latest NEO, CHE, RDNT, and LFST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/8/2026Q3 2026
RadNet, Inc. stock logo
RDNT
RadNet
$0.2214$0.30+$0.0786$0.05$639.97 million$638.26 million
11/5/2026Q3 2026
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$0.0369$0.06+$0.0231$0.06$431.59 million$455.86 million
10/28/2026Q3 2026
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$0.0555$0.07+$0.0145-$0.06$206.70 million$209.25 million
10/27/2026Q3 2026
Chemed Corporation stock logo
CHE
Chemed
$6.44$6.75+$0.31$5.45$685.04 million$690.94 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Chemed Corporation stock logo
CHE
Chemed
$2.800.51%+10.76%13.40%16 Years
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
N/AN/AN/AN/AN/A
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
N/AN/AN/AN/AN/A
RadNet, Inc. stock logo
RDNT
RadNet
N/AN/AN/AN/AN/A

Latest NEO, CHE, RDNT, and LFST Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/6/2026
Chemed Corporation stock logo
CHE
Chemed
quarterly$0.700.51%11/16/202611/16/202612/4/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Chemed Corporation stock logo
CHE
Chemed
0.27
1.11
1.08
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
0.17
1.44
1.44
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
0.47
3.53
3.31
RadNet, Inc. stock logo
RDNT
RadNet
0.90
1.49
1.49

Institutional Ownership

CompanyInstitutional Ownership
Chemed Corporation stock logo
CHE
Chemed
95.85%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
85.50%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
98.50%
RadNet, Inc. stock logo
RDNT
RadNet
77.90%

Insider Ownership

CompanyInsider Ownership
Chemed Corporation stock logo
CHE
Chemed
3.33%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
3.50%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
1.10%
RadNet, Inc. stock logo
RDNT
RadNet
5.14%
CompanyEmployeesShares OutstandingFree FloatOptionable
Chemed Corporation stock logo
CHE
Chemed
15,81113.02 million12.58 millionOptionable
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
10,961380.19 million366.88 millionOptionable
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
2,500129.39 million127.97 millionOptionable
RadNet, Inc. stock logo
RDNT
RadNet
11,26478.78 million74.73 millionOptionable

Recent News About These Companies

RadNet (NASDAQ:RDNT) EVP Sells $3,506,335.11 in Stock
RadNet (NASDAQ:RDNT) Stock Gets Price Target Increase from KeyCorp
RadNet (NASDAQ:RDNT) Downgraded by Zacks Research to Hold
RadNet: 3 Key Takeaways for Long-Term Investors
RadNet: A 'Buy' On Sizable Q3 Beat And Value-Generating M&A
RadNet (RDNT) Q3 2026 Earnings Call Transcript
RadNet, Inc. (RDNT) Q3 2026 Earnings Call Transcript
RadNet Q3 Earnings Call Highlights

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Chemed stock logo

Chemed NYSE:CHE

$547.16 +0.41 (+0.07%)
Closing price 03:59 PM Eastern
Extended Trading
$542.69 -4.47 (-0.82%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

LifeStance Health Group stock logo

LifeStance Health Group NASDAQ:LFST

$13.77 -0.40 (-2.82%)
Closing price 04:00 PM Eastern
Extended Trading
$13.81 +0.04 (+0.31%)
As of 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

NeoGenomics stock logo

NeoGenomics NASDAQ:NEO

$15.29 +0.04 (+0.26%)
Closing price 04:00 PM Eastern
Extended Trading
$15.30 +0.01 (+0.03%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

RadNet stock logo

RadNet NASDAQ:RDNT

$71.82 -3.10 (-4.14%)
Closing price 04:00 PM Eastern
Extended Trading
$72.51 +0.69 (+0.97%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.